# Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/second-line-treatments-for-the-management-of-advanced-renal-cell-carcinoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | James Larkin,Abby Paine,Indra Tumur,Joseph C. Cappelleri,Paul J. Healey,Grace Foley,Stephen Mitchell,Michel Kroes,Connie Chen |
| Citations | 22 |
| DOI | 10.1517/14656566.2013.758713 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2081505922 |
| PMID | 23256638 |
| Type | review |
| Year | 2012 |

## Paper authors

- [Michel Kroes](https://scholariq.org/researchers/michel-kroes/)

## Paper journal

- [Expert Opinion on Pharmacotherapy](https://scholariq.org/journals/expert-opinion-on-pharmacotherapy/)

## Paper primary topic

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Paper topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)
- [Microbial metabolism and enzyme function](https://scholariq.org/topics/microbial-metabolism-and-enzyme-function/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.